BostonGene to Present Multimodal AI Advances in Oncology at ESMO Congress
Rapid Read

BostonGene to Present Multimodal AI Advances in Oncology at ESMO Congress

What's Happening? BostonGene, an AI model developer for tumor and immune biology, will present its advancements in multimodal AI at the ESMO AI & Digital Oncology Congress 2026 in Berlin, Germany. The company will showcase how its AI platform addresses critical oncology challenges, including accurat
AI Generated
This may include content generated using AI tools. Glance teams are making active and commercially reasonable efforts to moderate all AI generated content. Glance moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. Glance encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. Glance maintains that all AI generated content here is for entertainment purposes only.